High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome.
暂无分享,去创建一个
H. Karch | M. Bitzan | K. Ludwig | D. Müller-wiefel | J. Heesemann | E. Moebius | D. Müller‐Wiefel | Jürgen Heesemann | Martin Bitzan | Helge Karch | Eckehard Moebius | Dirk E. Müller-Wiefel
[1] D. Milford,et al. Literature abstracts , 2004, Pediatric nephrology (Berlin, West).
[2] P. Tarr,et al. Escherichia coli 0157:H7 and the Hemolytic Uremic Syndrome: Importance of Early Cultures in Establishing the Etiology , 1990 .
[3] V. Gannon,et al. Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. , 1990, Journal of general microbiology.
[4] G. Reuter,et al. Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattle , 1990, Journal of clinical microbiology.
[5] H. Karch,et al. [Hemolytic-uremic syndrome in infants due to verotoxin-producing Escherichia coli]. , 1990, Deutsche medizinische Wochenschrift.
[6] Y. Takeda,et al. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. , 1990, Microbial pathogenesis.
[7] T. Barrett,et al. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice , 1989, Infection and immunity.
[8] L. Pickering,et al. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. , 1989, The Journal of infectious diseases.
[9] B. Rowe,et al. Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. , 1989, Journal of Clinical Pathology.
[10] H. Karch,et al. Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli , 1989, Journal of clinical microbiology.
[11] T. Barrett,et al. Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. , 1989, The Journal of infectious diseases.
[12] B. Rowe,et al. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome , 1989, Journal of clinical microbiology.
[13] M. Karmali,et al. Infection by verocytotoxin-producing Escherichia coli , 1989, Clinical Microbiology Reviews.
[14] C. Lingwood,et al. Verotoxin receptor glycolipid in human renal tissue. , 1989, Nephron.
[15] C. MacKenzie,et al. Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. , 1988, Microbial pathogenesis.
[16] L. Pickering,et al. Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. , 1988, The Journal of pediatrics.
[17] H. Karch,et al. Purification and characterization of a phage-encoded cytotoxin from an Escherichia coli O111 strain associated with hemolytic-uremic syndrome. , 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.
[18] M. P. Jackson,et al. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine , 1988, Journal of bacteriology.
[19] L. Becker,et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.
[20] H. Karch,et al. Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. , 1988, Microbial pathogenesis.
[21] H. Yeger,et al. Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157:H7 , 1988, Journal of clinical microbiology.
[22] B. Rowe,et al. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. , 1988, Journal of medical microbiology.
[23] H. Karch,et al. Hemolytic‐uremic syndrome associated with a variant Shiga‐like cytotoxin of Escherichia coli O111 , 1988, The Pediatric infectious disease journal.
[24] M. Bitzan,et al. Yersinia enterocolitica serodiagnosis: a dual role of specific IgA. Evaluation of microagglutination and ELISA. , 1987, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.
[25] A. Borczyk,et al. FALSE POSITIVE IDENTIFICATIONS OF ESCHERICHIA COLI 0157 , 1987, The Lancet.
[26] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.
[27] P. Rose,et al. Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. , 1985, Journal of clinical pathology.
[28] H. Karch,et al. Analysis of electrophoretically heterogeneous lipopolysaccharides of Escherichia coli by immunoblotting , 1984 .
[29] H. Karch,et al. Alteration of the immunoglobulin G subclass responses in mice to lipopolysaccharide: effects of nonbacterial proteins and bacterial membrane phospholipids or outer membrane proteins of Proteus mirabilis , 1983, Infection and immunity.
[30] Harry B. McGee,et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype , 1983 .
[31] M. Petric,et al. SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS , 1983, The Lancet.
[32] M. Thompson,et al. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. , 1982, The Journal of infectious diseases.
[33] D. Carlo,et al. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. , 1978, Analytical biochemistry.
[34] J Konowalchuk,et al. Vero response to a cytotoxin of Escherichia coli , 1977, Infection and immunity.
[35] R. Fieve,et al. Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study. , 1974, Lancet.
[36] G. Takátsy. The use of spiral loops in serological and virological micro-methods. , 1955, Acta microbiologica Academiae Scientiarum Hungaricae.